Cholesterol Restriction Primes RIG-I Antiviral Responses Through a Noncanonical Type I IFN Pathway
Tasuku Nishimura, Takahisa Kouwaki, Ken Takashima, Akie Ochi, Yohana Silas Mtali, Hiroyuki Oshiumi
This study shows that cholesterol restriction enhances RIG-I antiviral responses via a noncanonical type I IFN pathway, with implications for viral pandemic treatments.
EMBO Reports · Dec 12, 2024Peer-reviewedImmunology